Latest News

  • Nature-Inspired ‘Signaling Cascade’ Enables Drug Monitoring at Home

    Diagnostics World | When patients are prescribed drugs with a narrow therapeutic window, where the difference between an effective and toxic dose can be frighteningly small, therapeutic drug monitoring is crucial to their safety. Outside of a hospital setting with expensive lab equipment and specialized staff to do the monitoring, things can get dicey.

    Oct 30, 2025

  • Pangaea Launches Next-Gen Platform, EpiSign’s METRIC Released, Biodesix, Bio-Rad Laboratories Partner Up

    Diagnostics World | Pangaea launches its next-generation platform; EpiSign launches its Methylation-based Episignature Testing and Reference-based Interpretation & Classification (METRIC); Biodesix signs an expanded partnership agreement with Bio-Rad Laboratories; and more.

    Oct 29, 2025

  • Follow the Money: Obesity Weight Loss Drug, Trojan Horse Approach for Diseases, More

    Diagnostics World | Kailera Therapeutics advances their obesity portfolio; Trogenix combines cancer cell killing and immune stimulation, delivered via a Trojan Horse approach that reawakens the immune system; and more.

    Oct 28, 2025

  • New AI Tool Addresses Data Accuracy and Fairness

    Diagnostics World | Modern healthcare algorithms are trained with large volumes of data and can recognize patterns and correlate them with outcomes. However, there is still the issue of bias against underrepresented groups, even though these algorithms are trained using diverse populations. Researchers from the Icahn School of Medicine at Mount Sinai have developed AEquity, a tool of identification that reduces biases in datasets used to train machine learning algorithms.

    Oct 24, 2025

  • MyHeritage Adopts Whole Genome Sequencing for Their DNA Tests

    Diagnostics World | Earlier this month, MyHeritage announced that they have upgraded their at-home DNA tests to have Whole Genome Sequencing. By utilizing Ultima Genomics’ sequencing technology and processing at the Gene by Gene lab, MyHeritage is the first major commercial DNA testing company to adopt Whole Genome Sequencing at such a massive scale of over one million tests per year.

    Oct 22, 2025

  • New Glycan-Based Diagnostic May Refine Cancer Detection and Treatment

    Diagnostics World | A new diagnostic tool could soon help oncologists identify which tumors are most vulnerable to a class of immunotherapies that target cancer’s sugar-coated surface. Researchers at the UC Irvine School of Medicine have developed a companion diagnostic that measures glycan density in tumor tissue, which could redefine how solid tumors are detected, classified, and treated.

    Oct 16, 2025

  • GPT Model Could Serve as ‘Early Warning System’ of Disease Risk

    Diagnostics World | An innovative GPT model trained on vast amounts of anonymized data from healthy volunteers in the UK Biobank has been shown to be impressively good at predicting an individual’s risk of developing over 1,200 diseases over the next decade. Since the model represents disease risks as rates, it can also quantify how quickly new cases occur within a population over time.

    Oct 15, 2025

  • A Look at Early Rheumatoid Arthritis Paves New Paths Forward

    Diagnostics World | As people with rheumatoid arthritis (RA) well know, it is a “forever disease” with no single magic-bullet cure or guarantee that they will ever feel like they did before their diagnosis. But a better understanding of what’s happening biologically before the first swollen joint appears could reveal opportunities to markedly modify the course of RA and, ultimately, prevent it.

    Oct 14, 2025